Stay updated on Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial page.

Latest updates to the Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial page
- Check3 days agoChange DetectedThe page revision was updated to v3.5.3, indicating a newer version of the page. This likely reflects internal updates or fixes and does not imply changes to the displayed study information.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 on the study page.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check46 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision: v3.4.3 is now shown on the page. The previous revision label v3.4.2 has been removed.SummaryDifference0.1%

- Check81 days agoChange DetectedAdded Revision: v3.4.2; removed the prior Revision: v3.4.1 and the government funding status notice.SummaryDifference0.4%

- Check89 days agoChange DetectedA system-wide notice about a lapse in government funding was added and the site revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial page.